Skip to content
10-Q

Quarterly Report

REIN THERAPEUTICS, INC. RNTX

0001193125-25-281622

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 26.29M sh
Shares Diluted Q3 2025 · Sep 30, 2025 26.36M sh
Shares Diluted Q3 2025 · Sep 30, 2025 24.17M sh
Shares Diluted Q3 2025 · Sep 30, 2024 21.66M sh
Shares Diluted Q3 2025 · Sep 30, 2024 16.69M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$16.14M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$17.48M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $4.05M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $12.87M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $17.65M
Stockholders Equity Q3 2025 · Sep 30, 2025 $46.19M
Stockholders Equity Q3 2025 · Jun 30, 2025 $48.01M
Stockholders Equity Q3 2025 · Mar 31, 2025 $49.88M
Stockholders Equity Q3 2025 · Dec 31, 2024 $54.39M
Stockholders Equity Q3 2025 · Sep 30, 2024 $95.23M
Stockholders Equity Q3 2025 · Jun 30, 2024 $101.02M
Stockholders Equity Q3 2025 · Mar 31, 2024 $91.33M
Stockholders Equity Q3 2025 · Dec 31, 2023 $98.3M
Current Liabilities Q3 2025 · Sep 30, 2025 $5.74M
Current Liabilities Q3 2025 · Dec 31, 2024 $5.75M
Total Liabilities Q3 2025 · Sep 30, 2025 $7.52M
Total Liabilities Q3 2025 · Dec 31, 2024 $7.8M
Current Assets Q3 2025 · Sep 30, 2025 $5.17M
Current Assets Q3 2025 · Dec 31, 2024 $13.66M
Total Assets Q3 2025 · Sep 30, 2025 $53.71M
Total Assets Q3 2025 · Dec 31, 2024 $62.19M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.21
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.74
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.27
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.31
Eps Basic Q3 2025 · Sep 30, 2025 −$0.21
Eps Basic Q3 2025 · Sep 30, 2025 −$0.74
Eps Basic Q3 2025 · Sep 30, 2024 −$0.27
Eps Basic Q3 2025 · Sep 30, 2024 −$1.31
Sga Expense Q3 2025 · Sep 30, 2025 $3.81M
Sga Expense Q3 2025 · Sep 30, 2025 $8.94M
Sga Expense Q3 2025 · Sep 30, 2024 $2.35M
Sga Expense Q3 2025 · Sep 30, 2024 $11.39M
Rd Expense Q3 2025 · Sep 30, 2025 $1.68M
Rd Expense Q3 2025 · Sep 30, 2025 $9.03M
Rd Expense Q3 2025 · Sep 30, 2024 $3.72M
Rd Expense Q3 2025 · Sep 30, 2024 $10.93M
Net Income Q3 2025 · Sep 30, 2025 −$5.58M
Net Income Q3 2025 · Sep 30, 2025 −$17.9M
Net Income Q3 2025 · Jun 30, 2025 −$6.82M
Net Income Q3 2025 · Mar 31, 2025 −$5.5M
Net Income Q3 2025 · Sep 30, 2024 −$5.85M
Net Income Q3 2025 · Sep 30, 2024 −$21.9M
Net Income Q3 2025 · Jun 30, 2024 −$8.94M
Net Income Q3 2025 · Mar 31, 2024 −$7.11M
Operating Income Q3 2025 · Sep 30, 2025 −$5.49M
Operating Income Q3 2025 · Sep 30, 2025 −$17.97M
Operating Income Q3 2025 · Sep 30, 2024 −$6.07M
Operating Income Q3 2025 · Sep 30, 2024 −$22.32M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $0